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Clinical Case Report
ABSTRACT
Angiosarcoma is a rare neoplasm, constituting only 2% of all the soft tissue tumors and most frequently involves the 
skin of the head and neck region in elderly males. They are extremely aggressive tumors with high rates of metastasis 
and poor outcomes. We report a unique case of angiosarcoma involving an unusual site – upper alveolus and maxilla 
in a young patient highlighting the diagnostic challenges in such a scenario. A 29 years old female presented with a 
non-healing wound of the oral cavity, which had progressed to the current maximum size of 6.4 cm within one month. 
Magnetic resonance imaging (MRI) scan revealed the involvement of maxilla up to the floor of the orbit and adjacent soft 
tissue. However, no distant metastasis was detected on Positron Emission Tomography (PET) scan. Biopsy of the lesion 
showed an irregular, highly pleomorphic, and mitotically active epithelioid soft tissue tumor conclusively diagnosed as 
angiosarcoma. 
Keywords  
Maxilla; Oral Ulcer: Rare Diseases; Sarcoma.
INTRODUCTION
Angiosarcomas are rare, aggressive malignant 
sarcomas arising from vascular endothelial cells. They 
constitute 2% of all the soft tissue sarcomas.1 Tumors 
may arise at any anatomic location, but the skin of 
the head and neck and breast (arising in chronic 
lymphedema secondary to modified radical mastectomy) 
are frequently involved. The typical presentation is a 
scalp lesion in older Caucasian men.2 Angiosarcomas 
are rare in children and young adults.3 They are 
rapidly progressing tumors that metastasize early and 
commonly recur locally even after surgical removal. 
These factors contribute to a reduced overall survival, 
with almost half of the patients dying within 15 months 
of diagnosis.4,5 We present the case of angiosarcoma 
in a relatively young adult, which appeared at a very 
rare site, underlining the diagnostic conundrum and 
pointers towards an accurate diagnosis.
CASE REPORT
A 29-year-old female presented with a non-
healing wound of the oral cavity, which she had 
had for 1 month. It was rapidly progressing in size. 
Apparently, she was asymptomatic 1 month earlier, 
when she developed an ulcer in the left upper 
alveolus with associated occasional minimal bleeding. 
She underwent alternative treatment, but the lesion 
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progressed in size. There was no significant family 
history, and she was a non-smoker, did not drink 
alcohol, and had no previous history of any chronic 
illness. On examination, a 4 × 4 cm proliferative 
lesion in the left upper alveolus was noted, involving 
the upper gingivobuccal sulcus and the palate 
(Figures 1A and 1B). A blue hue was discerned over the 
surface of the lesion, and it occasionally bled on touch. 
There was no cervical lymphadenopathy on palpation.
A magnetic resonance imaging (MRI) scan 
of the paranasal sinuses and the neck revealed a 
heterogeneously enhanced expansile soft tissue 
mass arising from the left upper alveolus, which 
measured 6.4 × 5.2 × 5.6 cm (Figure 2A). A computed 
tomography (CT) scan showed that it had eroded the 
adjacent alveolar process and lateral wall of the maxilla, 
extending superiorly into the left maxillary sinus up 
to the orbital floor, the lateral pterygoid plate up to 
the skull base, and laterally into the subcutaneous 
plane. A positron emission tomography-computed 
tomography (PET-CT) scan revealed a primary avid 
maxillary tumor (Figure 2B); however, there was no 
metastatic lesion (Figure 2C).
A biopsy was performed from the mass; the 
histopathological examination revealed an irregular 
subepithelial tumor composed of proliferating vascular 
Figure 1. A and B – Physical examination findings showing marked swelling in the left cheek with upper alveolus 
and palate involvement.
Figure 2. A – MRI T2 weighted image displaying the tumor extension; B – PET-CT scan demonstrating a 
fluorodeoxyglucose (FDG) avid tumor; C – Whole body positron emission tomography-computed tomography 
(PET-CT) scan without distant metastases.
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channels filled with blood. The lining cells were 
highly pleomorphic and mostly epithelioid, exhibiting 
round-to-oval vesicular nuclei along with prominent 
nucleoli (Figures 3A and 3B). Areas of spindle cell 
proliferation were also identified, as well as large areas of 
hemorrhage, significant necrosis, and a high mitotic rate 
(>20/10 hpf). On immunohistochemistry (IHC), the tumor 
cells were positive for CD31 (Figure 3C), FLI-1 (Figure 3D), 
CD34 (Figure 4A) and focally for AE1/AE3 (Figure 4B). 
The Ki-67 proliferation index was approximately 75-80% 
in the highest proliferation zone. These features pointed 
towards a diagnosis of angiosarcoma.
Figure 3. Photomicrographs of the tumor. A – subepithelial irregular vascular tumor (H&E, 10X); B – highly pleomorphic 
epithelioid tumor cells lining the vascular spaces (H&E, 40X); C – the tumor cells were diffusely positive for CD31 (10X); 
D – positive reaction to FLI-1 (10X); E – focally positive for CD34 (40X); F – focally positive for AE1/AE3 (10X).
Figure 4. Photomicrographs of the tumor. A- Immunohistochemical reaction focally positive for CD34 (40X); and 
for AE1/AE3 in B (10X).
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Due to the involvement of the lateral pterygoid 
plate and the skull base, the tumor was inoperable. 
The patient was scheduled for palliative chemotherapy 
and radiation, but she did not turn up for the treatment.
DISCUSSION
Angiosarcoma is one of the rarest soft tissue 
tumors. It occurs most commonly in the skin or 
subcutaneous tissue of sun-exposed areas due to 
ultraviolet light exposure.1,2 Most of the cases are 
sporadic, and the potential causes of occurrence 
include radiation exposure, chemicals, or chronic 
lymphedema.4 History of trauma is cited as one of the 
causes, but authors believe it merely draws attention 
to a pre-existing lesion.1 However, our patient did not 
have any history of exposure to these risk factors.
Angiosarcoma is seldom encountered in young 
individuals, and our patient was only 29 years old. 
The usual mean age of patients is more than 70 years. 
In the SEER database of 1,250 primary head and 
neck angiosarcoma, only 1.3% of patients were 
younger than 30 years.2 Angiosarcoma is associated 
with congenital diseases, such as neurofibromatosis, 
bilateral retinoblastoma (Rb1 deletion), Klippel-
Trenaunay syndrome, Aicardi syndrome, or xeroderma 
pigmentosum, which suggests a genetic association in 
young patients.6
Males are more commonly affected than females 
(2-3:1). Additionally, the site of involvement in our 
patient was very rare. In the SEER database, 93.5% of 
tumors were found to be cutaneous, and only 1.6% 
(n = 20) involved facial bones, buccal mucosa, or 
gums.1,2 Occasionally, metastatic tumors to the oral 
cavity have been reported from a primary tumor in the 
scalp or other locations.7
The clinical differential diagnosis in the present 
case included squamous cell carcinoma, hemangioma/
vascular lesion, melanoma, or metastatic disease. 
Squamous cell carcinoma was included because it is 
the most common oral malignancy;8 vascular tumors 
due to the bluish hue over the lesion; and melanoma 
or metastatic disease due to the rapid growth of the 
lesion.
Rendering a diagnosis of angiosarcoma in an oral 
cavity lesion in a relatively young adult patient is a 
difficult proposition, due in part to (i) the rarity of the 
entity in this age group; (ii) the uncommon site; and (iii) 
the significant clinical consequences of this diagnosis. 
The histomorphology can be variable, ranging from 
highly differentiated tumors resembling benign or 
intermediate-grade vascular lesions (e.g., hemangioma 
or hemangioendothelioma), to anaplastic lesions that 
are difficult to distinguish from a poorly differentiated 
carcinoma or other high-grade sarcomas.9
The typical picture is composed of anastomosing 
vascular spaces lined by atypical plump epithelioid-to-
spindle cells with multilayering, and brisk mitosis and 
necrosis. In contrast to hemangiomas, the vascular 
channels in angiosarcoma seem to create their tissue 
planes, dissecting through the collagen and fascia; 
the tumor cells usually have larger hyperchromatic 
nuclei and often pile up along the lumens creating 
papillations.6 Hemangioendotheliomas can be excluded 
in the presence of extensive necrosis, marked cytologic 
atypia, epithelioid morphology, and brisk mitosis.3 An 
epithelioid morphology, a lack of obvious vasoformative 
foci, and frequent cytokeratin positivity may lead to 
an erroneous diagnosis of poorly differentiated 
metastatic (or primary) carcinoma.6 Pseudovascular 
adenoid or acantholytic squamous cell carcinoma 
can mimic angiosarcoma in the oral cavity on 
histology.10 Histopathological features, which are 
helpful in distinguishing epithelioid angiosarcoma from 
poorly differentiated metastatic/primary carcinoma, 
include occasional intracytoplasmic vacuoles with 
or without red blood cells, anastomosing vascular 
channels, and the lack of a desmoplastic reaction 
encountered in the former. Furthermore, strong 
immunoreactivity for vimentin, coupled with endothelial 
cell markers (Factor VIII, CD31, CD34) positivity, 
renders the diagnosis of metastatic carcinoma unlikely. 
The other differential diagnostic possibilities include 
malignant melanoma and epithelioid sarcoma.9,11 In 
addition to subtle histological differences, a panel of 
IHC markers, including positive staining for vascular 
markers and negative immunostaining for HMB-
45, Melan-A, S 100, and CD45 readily exclude the 
diagnostic mimics.11,12 Notably, INI-1 was retained 
in our case, which helped to rule out an important 
mimicker—namely epithelioid sarcoma.13
Immunostaining with vimentin shows strong and 
diffuse positivity in angiosarcoma. The endothelial 
markers, CD31 and Factor VII I, are positive in 
nearly 100% of cases. CD34 positivity ranges from 40% 
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to 100%;12 however, it is not a specific marker and is 
positive in very close morphological mimics, namely 
epithelioid sarcoma and solitary fibrous tumor. 
FLI1, a nuclear transcription factor, identifies more 
than 95% of vascular tumors regardless of the type 
and grade.14 However, it is also expressed in Ewing 
sarcoma, subsets of a wide range of mesenchymal 
tumors, subsets of high-grade lymphomas including 
lymphoblastic lymphomas and diffuse large B-cell 
lymphomas, and even subsets of carcinomas and 
melanomas. Thus, it has limited utility by itself owing 
to its low specificity.11 Another nuclear transcription 
factor, ERG, is an exquisitely sensitive endothelial 
marker of vascular differentiation and is retained in 
even poorly differentiated angiosarcomas.13 However, 
ERG is also expressed in a subset of Ewing sarcomas 
(5-10%), prostatic adenocarcinomas, and a small 
subset of acute myeloid leukemia.11 Among the 
vascular markers, CD31 is the most sensitive and 
specific antigen for endothelial differentiation; in 
combination with FLI-1, it helps the confident diagnosis 
of angiosarcomas.1,6,9 CD31 and FLI-1 positivity 
can be misleading, and a mistaken diagnosis of 
atypical fibroxanthoma is sometimes made; however, 
morphological details can help to avoid this.1 Cytokeratin 
and epithelial membrane antigen positivity has been 
reported in up to 50% of epithelioid angiosarcomas 
focally, which was our finding as well.15 These markers 
could be potential diagnostic pitfalls and quandaries, so 
they should be used and interpreted in the appropriate 
clinicopathologic settings.
Surgery is the modality of choice for squamous 
cell carcinomas or sarcomas. Since the tumor was 
inoperable in our case due to the lateral pterygoid 
plate’s involvement up to the skull base, palliative 
chemotherapy and radiation were the treatment options 
available. The definite histopathological diagnosis in 
such cases has major treatment implications. Squamous 
cell carcinomas are radiosensitive while sarcomas or 
melanomas do not respond to radiotherapy.16 Advanced 
malignant melanomas are tested for BRAF V600E 
mutations, and based on that, they are treated 
either with BRAF inhibitors and MEK inhibitors, or 
immunotherapy.17 In the case of metastatic carcinoma, 
the therapy is based on the primary tumor type. On the 
other hand, paclitaxel-based systemic chemotherapy 
is the preferred regimen for angiosarcomas. Tyrosine 
kinase inhibitors (TKI) have been used to inhibit the 
vascular endothelial growth factor (VEGF) signaling 
pathway. Although a few studies have reported some 
promising results with TKI (e.g., sorafenib), there is no 
proven benefit.18 The other treatment options include 
chemotherapy with recombinant interleukin-2, or 
radiotherapy in a few cases, especially in the form of 
concurrent chemoradiation.19
However, the prognosis in angiosarcomas is 
dismal owing to early metastasis and multiple lesions. 
Up to 32% of patients have metastatic lesions at 
the time of diagnosis.20 The 5-year overall survival 
and disease-free survival is 26.5% and 48.3%, 
respectively.2 In multivariate analysis, age ≥70 years, 
tumor size of ≥5 cm, and the presence of metastasis at 
the time of diagnosis were the independent prognostic 
factors. Among them, the presence of metastasis is the 
most important since its presence increases the risk of 
overall and disease-specific death by 197% and 399%, 
respectively.2
To conclude, we present an exceedingly rare 
angiosarcoma case with respect to the unusual age at 
presentation and the site of involvement. Within the 
oral cavity, the differential diagnoses are varied and 
may be challenging in various scenarios. The pathology 
pearls must be borne in mind to surmount the 
diagnostic challenges. The treatment modalities also 
need to be tailored, considering the whole scenario. 
Nevertheless, the overall survival of patients is grim 
with these aggressive sarcomas.
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